Pressure support ventilation attenuates ventilator-induced protein modifications in the diaphragm.

Abstract

Common medical conditions that require mechanical ventilation include chronic obstructive lung disease, acute lung injury, sepsis, heart failure, drug overdose, neuromuscular disorders, and surgery. Although mechanical ventilation can be a life saving measure, prolonged mechanical ventilation can also present clinical problems. Indeed, numerous well-controlled animal studies have demonstrated that prolonged mechanical ventilation results in diaphragmatic weakness due to both atrophy and contractile dysfunction. Importantly, a recent clinical investigation has confirmed that prolonged mechanical ventilation results in atrophy of the human diaphragm. This mechanical ventilation-induced diaphragmatic weakness is important because the most frequent cause of weaning difficulty is respiratory muscle failure due to inspiratory muscle weakness and/or a decline in inspiratory muscle endurance. Therefore, developing methods to protect against mechanical ventilation-induced diaphragmatic weakness is important.

• Authors: Scott K Powers, Marc DeCramer, Ghislaine Gayan-Ramirez, Sanford Levine
• Journal: Critical care (London, England) (Crit Care) Vol. 12 Issue 6 Pg. 191 ( 2008) ISSN: 1466-609X [Electronic] England
• PMID: 19040772 (Publication Type: Comment, Journal Article)

Chemical References

• Proteins

Topics

• Critical Illness
• Diaphragm (physiopathology)
• Humans
• Muscular Atrophy (etiology, physiopathology)
• Myofibrils (metabolism)
• Proteins (metabolism)
• Respiration, Artificial (adverse effects)
• Respiratory Paralysis (etiology, physiopathology)